Text Size

Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells

Yamamoto Y., Taniguchi T., Inazumi T., Iwamura R., Yoneda K., Odani-Kawabata N., Matsugi T., Sugimoto Y., Shams N.K.


  • 2020
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    Research and Development Division, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma-shi, Nara, 630-0101, Japan; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan; Research and Development Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan; Research and Development Division, Santen, Inc., Emeryville, CA, United States

Related Publications

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.


Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches

Acott T.S.; Fautsch M.P.; Mao W.; Ethier C.R.; Huang A.S.; Kelley M.J.; Aga M.; Bhattacharya S.K.; Borras T.; Bovenkamp D.; Chowdhury U.R.; Clark A.F.; Dibas M.I.; Du Y.; Elliott M.H.; Faralli J.A.; Gong H.; Herberg S.; Johnstone M.A.; Kaufman P.L.; Keller K.E.; Kelly R.A.; Krizaj D.; Kuehn M.H.; Li H.L.; Lieberman R.; Lin S.C.; Liu Y.; McDonnell F.S.; McDowell C.M.; McLellan G.J.; Mzyk P.; Nair K.S.; Overby D.R.; Peters D.M.; Raghunathan V.; Rao P.V.; Roddy G.W.; Sharif N.A.; Shim M.S.; Sun Y.; Thomson B.R.; Toris C.B.; Willoughby C.E.; Zhang H.F.; Freddo T.F.; Fuchshofer R.; Hill K.R.; Karimi A.; Kizhatil K.; Kopcyznski C.C.; Liton P.; Patel G.; Peng M.; Pattabiraman P.P.; Prasanna G.; Reina-Torres E.; Samples E.G.; Samples J.R.; Steel C.L.; Strohmaier C.A.; Subramanian P.; Sugali C.K.; van Batenburg-Sherwood J.; Wong C.; Youngblood H.; Zode G.S.; White E.; Stamer W.D.


Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022